Trinity Biotech Oxalate


Oxalate was confirmed as a normal constituent of urine in 1951, but only recently has the significance of calcium oxalate crystalluria and its relationship to urinary tract stone formation been fully recognised. Formation of the sparingly soluble calcium salt of oxalate in the urinary tract is considered the major factor in urolithiasis.


Enzymatic, Colormetric, Endpoint


Indamine dye has an absorbance maximum of 590nm. The intensity of the colour produced is directly proportional to the concentration of Oxatale in the sample.

Product information


A decreased excretion of oxalate in the urine is associated with hyperglycinemia or hyperglycinuria.An Increased excretion of oxalate in the urine can be attributed to: Increases in ingestion of oxalate precursors or oxalate rich foods. Formation of oxalate due to metabolic defects such as in primary hyperoxaluria. Absorption of oxalate in a number of gastrointestinal disorders that produce severe fat malabsorption. This is indicative of patients with inflammatory bowel disease, ideal resection, biliary diversion, pancreatic insufficiency, small intestinal stasis with bacterial overgrowth, and following jejunoileal bypass or resection for the treatment of obesity.

Oxalate: Sample Purifier Tubes Trinity Biotech 591-100 100 tubes
Oxalate: Reagent B Trinity Biotech 591-2 2 ml
Oxalate: Urine Control – Elevated Trinity Biotech O6502 6×5 ml
Oxalate: Urine Control – Normal Trinity Biotech O6627 6×5 ml
Oxalate: Standard 0.50 MMOL/L Trinity Biotech 591-3 25 ml
Oxalate: Standards Set Trinity Biotech 591-11 6×25 ml
Oxalate: Reagent A Trinity Biotech 591-10 10 ml
Oxalate: Sample diluent Trinity Biotech 591-4 100 ml
Oxalate: Sample Purifier Tubes Trinity Biotech 591-20 20 tubes
Oxalate: Kit (100 assays) Trinity Biotech 591-D Maximum Assays : 100
Oxalate: Kit (20 assays) Trinity Biotech 591-C Maximum : 20 assays

Download Trinity Biotech Clinical Chemistry Catalogue PDF